- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.27 Å
- Oligo State
- hetero-2-2-1-mer
- Ligands
- 3 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 4 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 3 residues within 4Å:- Chain A: P.175, K.394
- Chain B: N.347
2 PLIP interactions:1 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:N.347
- Salt bridges: A:K.394
SO4.5: 3 residues within 4Å:- Chain B: T.221, G.223, R.276
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:T.221, B:G.223
- Salt bridges: B:R.276
SO4.10: 2 residues within 4Å:- Chain D: T.221, R.276
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:T.221, D:T.221, D:G.223
- Salt bridges: D:R.276
SO4.11: 3 residues within 4Å:- Chain D: H.227, R.276, G.277
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:G.277
- Salt bridges: D:K.19, D:H.227
- 1 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)
GDP.3: 16 residues within 4Å:- Chain B: G.10, Q.11, C.12, Q.15, S.138, G.141, G.142, T.143, G.144, P.171, V.175, D.177, E.181, N.204, Y.222, N.226
21 PLIP interactions:21 interactions with chain B- Hydrogen bonds: B:Q.11, B:C.12, B:S.138, B:G.142, B:T.143, B:T.143, B:G.144, B:V.175, B:D.177, B:N.204, B:N.204, B:Y.222, B:N.226, B:N.226
- Water bridges: B:G.13, B:D.67, B:N.99, B:L.139, B:T.143
- pi-Stacking: B:Y.222, B:Y.222
- 2 x JUL: 7-methoxy-4-[2-(morpholin-4-yl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]-3,4-dihydroquinoxalin-2(1H)-one(Non-covalent)
JUL.4: 20 residues within 4Å:- Chain A: T.179
- Chain B: Y.200, V.236, C.239, L.240, L.246, A.248, D.249, L.250, K.252, L.253, N.256, M.257, T.312, V.313, A.314, A.315, N.348, K.350, A.352
8 PLIP interactions:7 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:L.246, B:L.253, B:N.256, B:A.314, B:A.314, B:K.350, B:A.352
- Hydrogen bonds: A:T.179
JUL.9: 20 residues within 4Å:- Chain C: T.179, V.181
- Chain D: Y.200, V.236, C.239, L.240, L.246, A.248, D.249, L.250, K.252, L.253, N.256, M.257, V.313, A.314, A.315, N.348, K.350, A.352
8 PLIP interactions:7 interactions with chain D, 1 interactions with chain C- Hydrophobic interactions: D:L.246, D:N.256, D:A.314, D:A.314, D:K.350, D:K.350, D:A.352
- Hydrogen bonds: C:T.179
- 1 x MG: MAGNESIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pochampally, S. et al., Design, Synthesis, and Biological Evaluation of Pyrimidine Dihydroquinoxalinone Derivatives as Tubulin Colchicine Site-Binding Agents That Displayed Potent Anticancer Activity Both In Vitro and In Vivo. Acs Pharmacol Transl Sci (2023)
- Release Date
- 2023-04-12
- Peptides
- Tubulin alpha-1B chain: AC
Tubulin beta chain: BD
Stathmin-4: E - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CB
BD
DE
E
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.27 Å
- Oligo State
- hetero-2-2-1-mer
- Ligands
- 3 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 4 x SO4: SULFATE ION(Non-functional Binders)
- 1 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)
- 2 x JUL: 7-methoxy-4-[2-(morpholin-4-yl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]-3,4-dihydroquinoxalin-2(1H)-one(Non-covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pochampally, S. et al., Design, Synthesis, and Biological Evaluation of Pyrimidine Dihydroquinoxalinone Derivatives as Tubulin Colchicine Site-Binding Agents That Displayed Potent Anticancer Activity Both In Vitro and In Vivo. Acs Pharmacol Transl Sci (2023)
- Release Date
- 2023-04-12
- Peptides
- Tubulin alpha-1B chain: AC
Tubulin beta chain: BD
Stathmin-4: E - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CB
BD
DE
E